Poseida Therapeutics, Inc. Other Non-Current Liabilities
Poseida Therapeutics, Inc. had Other Non-Current Liabilities of $3.05 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2024-11-07
- 2024-09-30: Other Liabilities, Noncurrent $3.05M.
- 2024-06-30: Other Liabilities, Noncurrent $2.90M.
- 2024-03-31: Other Liabilities, Noncurrent $2.75M.
- 2023-12-31: Other Liabilities, Noncurrent $2.61M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2024-09-30 | $3.05M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $2.90M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $2.75M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.61M 10-Q · filed 2024-11-07 | |
| 2023-09-30 | $2.48M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.35M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $2.25M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $2.15M 10-K · filed 2024-03-07 | $2.09M 10-K · filed 2023-03-09 |
| 2022-09-30 | $1.97M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.84M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.70M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.59M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $1.48M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.37M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.27M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $1.17M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $1.08M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $992.00K 10-Q · filed 2020-08-20 | |
| 2019-12-31 | $5.42M 10-K · filed 2021-03-11 |